Relevance to NICE guidance programmes
This unlicensed use of oral glycopyrronium bromide for hyperhidrosis is not appropriate for referral for a NICE technology appraisal and is not currently planned into any other work programme.
No NICE guidance relevant to the treatment of hyperhidrosis or to the use of oral glycopyrronium bromide was identified.